Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03874351 · ClinicalTrials.gov registry record · NA

A Study of Home-Delivered Neurostimulation for Migraine

A NA study of Migraine Disorders, sponsored by MJHS Institute for Innovation in Palliative Care.

Completed
Registry status
NA
Development phase
22
Enrollment target
2
Study locations

NCT03874351 is a NA study of Migraine Disorders that has completed, run by MJHS Institute for Innovation in Palliative Care. The registered enrollment target is 22 participants, below the 314-participant average among 21 other Migraine Disorders trials with a reported enrollment target (93% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03874351, a NA study of Migraine Disorders, has completed, sponsored by MJHS Institute for Innovation in Palliative Care.

COMPLETED
Registry status
NA
Development phase
22 participants
Enrollment target
2
Study locations

Study Summary

There is a need for better preventive and abortive therapies for migraine. Previous research has indicated that non-invasive neurostimulation may have prophylactic effects on migraine and improve symptoms and functional outcomes in migraineurs. One such method is a non-invasive transcranial direct current stimulation (tDCS). This double-blind randomized sham-controlled two-parallel-arm study aims to evaluate efficacy and safety of tDCS self-delivered in daily 20-minute applications for 2 months (60 days) by adult migraine patients at home for migraine prevention and migraine symptom management, as compared to sham tDCS application; and to evaluate patients' satisfaction with the procedure.

Conditions Studied

Interventions

  • DEVICE non-invasive transcranial direct current stimulation (tDCS)

Study Locations (2)

New York

  • MJHS Institute for Innovation in Palliative Care - New York
  • New York Headache Center - New York

Trial Details

FieldValue
Enrollment Target 22 participants
Start Date 2019-04-22
Est. Completion 2020-05-12
Phase NA

What the Registry Record Tells You About NCT03874351

The ClinicalTrials.gov registry entry for NCT03874351 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 314-participant average among 21 other Migraine Disorders trials with a reported enrollment target (93% lower). The listed sponsor is MJHS Institute for Innovation in Palliative Care, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Migraine Disorders appearing as the primary indexed condition, and to 1 intervention - of which non-invasive transcranial direct current stimulation (tDCS) is the first listed.

NCT03874351 reports 2 study locations spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT03874351 about?

NCT03874351 is a clinical study titled "A Study of Home-Delivered Neurostimulation for Migraine". There is a need for better preventive and abortive therapies for migraine. Previous research has indicated that non-invasive neurostimulation may have prophylactic effects on migraine and improve symptoms and functional outcomes in migraineurs. One such method is a non-invasive transcranial direct c...

What is the current status of trial NCT03874351?

This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2019-04-22. Estimated completion is 2020-05-12.

What conditions does trial NCT03874351 study?

This clinical trial studies the following conditions: Migraine Disorders.

What interventions are being tested in trial NCT03874351?

The interventions under investigation include: non-invasive transcranial direct current stimulation (tDCS) (DEVICE).

Who is sponsoring clinical trial NCT03874351?

This trial is sponsored by MJHS Institute for Innovation in Palliative Care, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03874351 being conducted?

This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Migraine Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.